RESUMO
GPI-linked membrane folate receptors (MFRs) have been implicated in the receptor-mediated uptake of reduced folate cofactors and folate-based chemotherapeutic drugs. We have studied the biosynthetic transport to and internalization of MFR isoform alpha in KB-cells. MFR-alpha was synthesized as a 32-kD protein and converted in a maturely glycosylated 36-38-kD protein 1 h after synthesis. 32-kD MFR-alpha was completely soluble in Triton X-100 at 0 degree C. In contrast, only 33% of the 36-38-kD species could be solubilized at these conditions whereas complete solubilization was obtained in Triton X-100 at 37 degrees C or in the presence of saponin at 0 degree C. Similar solubilization characteristics were found when MFR-alpha at the plasma membrane was labeled with a crosslinkable 125I-labeled photoaffinity-analog of folic acid as a ligand. Triton X-100-insoluble membrane domains containing MFR-alpha could be separated from soluble MFR-alpha on sucrose flotation gradients. Only Triton X-100 soluble MFR-alpha was internalized from the plasma membrane. The reduced-folate-carrier, an integral membrane protein capable of translocating (anti-)folates across membranes, was completely excluded from the Triton X-100-resistant membrane domains. Internalized MFR-alpha recycled slowly to the cell surface during which it remained soluble in Triton X-100 at 0 degree C. Using immunoelectron microscopy, we found MFR-alpha along the entire endocytic pathway: in clathrin-coated buds and vesicles, and in small and large endosomal vacuoles. In conclusion, our data indicate that a large fraction, if not all, of internalizing MFR-alpha bypasses caveolae.
Assuntos
Proteínas de Transporte/metabolismo , Endocitose/fisiologia , Glicosilfosfatidilinositóis/metabolismo , Receptores de Superfície Celular/metabolismo , Transporte Biológico , Proteínas de Transporte/isolamento & purificação , Fracionamento Celular , Membrana Celular/química , Membrana Celular/metabolismo , Centrifugação com Gradiente de Concentração , Receptores de Folato com Âncoras de GPI , Ácido Fólico/análogos & derivados , Antagonistas do Ácido Fólico/metabolismo , Glicosilação , Complexo de Golgi/efeitos dos fármacos , Complexo de Golgi/metabolismo , Humanos , Ligantes , Microscopia Imunoeletrônica , Octoxinol/farmacologia , Oxirredução , Processamento de Proteína Pós-Traducional , Solubilidade , Células Tumorais CultivadasRESUMO
The role of a membrane-associated folate binding protein (mFBP) in transport of folate analogues was investigated in three epithelial cell lines that were grown in high folate medium and folate-conditioned medium and express different levels of mFBP: human nasopharyngeal KB cells, monkey kidney MA104 cells, and IGROV-I ovarian carcinoma cells. Folate analogues were selected for which mFBP exhibits a low affinity, i.e., methotrexate (MTX) and 10-ethyl-10-deazaaminopterin (10-EdAM) or a (moderately) high affinity as compared to folic acid, i.e., N-(5[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl(-N-m ethylamino]-2-theonyl)-L-glutamic acid (ZD1694), N10-propargyl-5,8-dideazafolic acid (CB3717), and 5,10-dideazatetrahydrofolic acid. Regardless of the medium folate status, growth inhibition studies with IGROV-I and MA104 cells demonstrated a lack of correlation between the affinity of mFBP for the antifolate drugs and their sensitivity profile; both cell lines were highly sensitive to growth inhibition by MTX, 10-EdAM, ZD1694 and 5,10-dideazatetrahydrofolic acid, but were insensitive for CB3717. The same drug sensitivity profile was observed for KB cells, with the exception that these cells were also sensitive to growth inhibition by CB3717 but only in folate-conditioned medium. This overall drug sensitivity profile appeared to correlate with the differential efficiency of drug transport via the "classical" reduced folate/MTX carrier (RFC), rather than by mFBP. Characteristics that further supported functional RFC activity in KB, IGROV-I, and MA104 cells included: (a) the growth inhibitory effects of the drugs could be prevented by the reduced folate leucovorin rather than by folic acid; (b) rates for uptake of [3H]10-EdAM were 2-4-fold higher than for [3H]MTX at 1 microM extracellular concentrations and coincided with the affinity of the RFC for these drugs, rather than those of the mFBP; (c) uptake of [3H]10-EdAM and [3H]leucovorin was markedly inhibited by leucovorin and 10-EdAM, respectively, or by an N-hydroxysuccinimide ester of MTX (irreversibly labeling RFC) but only to a minor extent by folic acid or an N-hydroxysuccinimide ester of folic acid (irreversibly labeling mFBP); and, finally, (d) labeling with an N-hydroxysuccinimide ester of [3H]MTX identified a protein with a molecular weight within the range of that reported for the RFC in human leukemic cells. Altogether, these results indicate that both RFC and mFBP are coexpressed in three epithelial cell lines and that RFC is the preferential route of entry for antifolate compounds, even when mFBP is expressed to very high levels.
Assuntos
Proteínas de Transporte/fisiologia , Antagonistas do Ácido Fólico/farmacologia , Receptores de Superfície Celular , Aminopterina/análogos & derivados , Animais , Divisão Celular/efeitos dos fármacos , Feminino , Receptores de Folato com Âncoras de GPI , Ácido Fólico/análogos & derivados , Ácido Fólico/metabolismo , Ácido Fólico/farmacologia , Antagonistas do Ácido Fólico/metabolismo , Glutamatos/biossíntese , Haplorrinos , Humanos , Rim/metabolismo , Rim/patologia , Leucovorina/metabolismo , Metotrexato/metabolismo , Metotrexato/farmacologia , Neoplasias Nasofaríngeas/metabolismo , Neoplasias Nasofaríngeas/patologia , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/patologia , Quinazolinas/metabolismo , Quinazolinas/farmacologia , Tetra-Hidrofolatos/metabolismo , Tetra-Hidrofolatos/farmacologia , Tiofenos/metabolismo , Tiofenos/farmacologia , Células Tumorais CultivadasAssuntos
Proteínas de Transporte/biossíntese , Receptor 2 de Folato/biossíntese , Receptores de Superfície Celular/biossíntese , Proteínas de Transporte/isolamento & purificação , Membrana Celular/metabolismo , Receptor 2 de Folato/isolamento & purificação , Receptores de Folato com Âncoras de GPI , Complexo de Golgi/metabolismo , Humanos , Células KB , Metionina/metabolismo , Octoxinol , SolubilidadeAssuntos
Proteínas de Transporte/metabolismo , Antagonistas do Ácido Fólico/metabolismo , Antagonistas do Ácido Fólico/toxicidade , Ácido Fólico/metabolismo , Receptores de Superfície Celular/metabolismo , Aminopterina/análogos & derivados , Aminopterina/metabolismo , Aminopterina/toxicidade , Transporte Biológico/efeitos dos fármacos , Proteínas de Transporte/biossíntese , Divisão Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Receptores de Folato com Âncoras de GPI , Ácido Fólico/análogos & derivados , Ácido Fólico/toxicidade , Humanos , Células KB , Cinética , Leucovorina/metabolismo , Metotrexato/metabolismo , Metotrexato/toxicidade , Quinazolinas/metabolismo , Quinazolinas/toxicidade , Relação Estrutura-AtividadeRESUMO
We have studied the role of N-linked oligosaccharides and proteolytic processing on the targeting of cathepsin D to the lysosomes in the human hepatoma cell line HepG2. In the presence of tunicamycin cathepsin D was synthesized as an unglycosylated 43-kDa proenzyme which was proteolytically processed via a 39-kDa intermediate to a 28-kDa mature form. Only a small portion was secreted into the culture medium. During intracellular transport the 43-kDa procathepsin D transiently became membrane-associated independently of binding to the mannose 6-phosphate receptor. Subcellular fractionation showed that unglycosylated cathepsin D was efficiently targeted to the lysosomes via intermediate compartments similar to the enzyme in control cells. The results show that in HepG2 cells processing and transport of cathepsin D to the lysosomes is independent of mannose 6-phosphate residues. Inhibition of the proteolytic processing of 53-kDa procathepsin D by protease inhibitors caused this form to accumulate intracellularly. Subcellular fractionation revealed that the procathepsin D was transported to lysosomes, thereby losing its membrane association. Procathepsin D taken up by the mannose 6-phosphate receptor also transiently became membrane-associated, probably in the same compartment. We conclude that the mannose 6-phosphate-independent membrane-association is a transient and compartment-specific event in the transport of procathepsin D.
Assuntos
Catepsina D/biossíntese , Lisossomos/enzimologia , Manosefosfatos/metabolismo , Processamento de Proteína Pós-Traducional , Amidoidrolases , Carcinoma Hepatocelular , Catepsina D/genética , Catepsina D/isolamento & purificação , Fracionamento Celular , Linhagem Celular , Centrifugação com Gradiente de Concentração , Glicosilação , Humanos , Neoplasias Hepáticas , Pepstatinas/farmacologia , Peptídeo-N4-(N-acetil-beta-glucosaminil) Asparagina Amidase , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Tunicamicina/farmacologiaRESUMO
We have assigned the biosynthetic processing steps of cathepsin D to intracellular compartments which are involved in its transport to lysosomes in HepG2 cells. Cathepsin D was synthesized as a 51-kDa proenzyme. After formation of 51-55-kDa intermediates due to processing of N-linked oligosaccharides, procathepsin D was proteolytically processed to an intermediate 44-kDa and the mature 31-kDa enzyme. The intersection of the biosynthetic pathway of cathepsin D with the endocytic pathway was labeled with horseradish peroxidase and monitored biochemically by 3,3'-diaminobenzidine cytochemistry. Horseradish peroxidase was used either as a fluid-phase marker to label the entire endocytic pathway or conjugated to transferrin (Tf) to label endosomes only. Directly after biosynthesis cathepsin D was accessible neither to horseradish peroxidase nor Tf-horseradish peroxidase. Newly synthesized 51-55-kDa species of cathepsin D present in the trans-Golgi reticulum were accessible to both horseradish peroxidase and Tf-horseradish peroxidase. The accessibility of trans-Golgi reticulum to both endocytosed horseradish peroxidase and Tf-horseradish peroxidase was monitored by colocalization with a secretory protein, alpha 1anti-trypsin. The proteolytic processing of 51-55-kDa to 44-kDa cathepsin D occurred in compartments which were fully accessible to fluid-phase horseradish peroxidase. Tf-horseradish peroxidase had access to only 20% of 44-kDa cathepsin D while it had no access to 31-kDa cathepsin D. In contrast, the 31-kDa species was completely accessible to fluid-phase horseradish peroxidase. We conclude that proteolytic processing of 51-55-kDa to 44-kDa cathepsin D occurs in endosomes, whereas the processing of 44-31-kDa cathepsin D takes place in lysosomes.
Assuntos
Catepsina D/biossíntese , Carcinoma Hepatocelular , Catepsina D/genética , Catepsina D/isolamento & purificação , Linhagem Celular , Centrifugação com Gradiente de Concentração , Eletroforese em Gel de Poliacrilamida , Complexo de Golgi/enzimologia , Peroxidase do Rábano Silvestre/metabolismo , Humanos , Cinética , Neoplasias Hepáticas , Metionina/metabolismo , Processamento de Proteína Pós-Traducional , Frações Subcelulares/enzimologia , Radioisótopos de Enxofre , alfa 1-Antitripsina/metabolismoRESUMO
The membrane association of the lysosomal enzymes cathepsin D and glucocerebrosidase and its naturally occurring sphingolipid activating protein was studied in HepG2 cells. We differentially permeabilized cells with low concentrations of saponin, at which secretory proteins rinsed out completely, whereas integral membrane proteins were not released. All relevant intracellular compartments were shown to be permeabilized by saponin. Metabolic labeling showed that early precursors of cathepsin D, sphingolipid activating protein, and glucocerebrosidase were completely released from the cells, whereas more than 80% of the high molecular mass intermediates were retained by the cells. Treatment of permeabilized cells with 10 mM mannose 6-phosphate released only 50% of the cell-associated cathepsin D. Glucocerebrosidase remained membrane-associated, but cathepsin D and sphingolipid activating protein were released from the cells after proteolytic processing. Sphingolipid activating proteins and cathepsin D behaved similarly during biosynthesis and showed similar sensitivity to mannose 6-phosphate. The membrane association of the intermediate form of cathepsin D was independent of the presence of N-linked oligosaccharides. Subcellular fractionation on sucrose gradients showed that the lysosomal proteins became membrane-associated probably in the Golgi complex, and that both mannose 6-phosphate-dependent and mannose 6-phosphate-independent membrane association occur in the same compartments. We conclude that, in HepG2 cells, cathepsin D, sphingolipid activating protein, and glucocerebrosidase exhibit MPR-independent membrane association which is acquired in the same compartments beyond the rough endoplasmic reticulum.
Assuntos
Carcinoma Hepatocelular/metabolismo , Catepsina D/metabolismo , Glucosilceramidase/metabolismo , Glicoproteínas/metabolismo , Neoplasias Hepáticas/metabolismo , Manosefosfatos/metabolismo , Membrana Celular/metabolismo , Eletroforese em Gel de Poliacrilamida , Humanos , Saposinas , Proteínas Ativadoras de Esfingolipídeos , Células Tumorais Cultivadas , Tunicamicina/farmacologiaRESUMO
Brefeldin A (BFA) rapidly blocks anterograde exocytotic transport through the Golgi complex. Sustained retrograde traffic induced by brefeldin A causes redistribution of constituents of the Golgi, but not the trans-Golgi network (TGN), to the endoplasmic reticulum (ER). In the present study on HepG2 cells, we have observed a differential effect of BFA on transport from the TGN of two soluble proteins: alpha 1-antitrypsin as a representative of secretory proteins and cathepsin D as a prototype of lysosomal enzymes. The Golgi complex of HepG2 cells is sensitive to BFA, as within minutes after its addition nearly all activity of three resident Golgi enzymes was recovered in the ER as monitored by cell fractionation on sucrose density gradients. In accordance with this, "high mannose"-glycosylated alpha 1-antitrypsin was retained in or transported back to the ER. "Complex"-glycosylated alpha 1-antitrypsin was neither secreted into the medium nor transported back to the ER. Most of it was retained in vesicles with the buoyant density of Golgi. These vesicles contained the fluid phase endocytotic marker horseradish peroxidase when this was added to the culture medium prior to the BFA, suggesting that the vesicles derived from the TGN. After BFA addition, the compartment became inaccessible to endocytosed horseradish peroxidase. In contrast to blocking transport of complex alpha 1-antitrypsin, BFA did not affect processing of newly synthesized complex-glycosylated procathepsin D (53 kDa) to the mature 31-kDa form. Neither did it interfere with processing of endocytosed procathepsin D. That the mature cathepsin D had indeed reached the lysosomes was verified by Percoll density gradient fractionation. In conclusion, in HepG2 cells, BFA induces two blocks in the secretory pathway: one at the level of the ER-Golgi juncture and the other in the TGN. In contrast, transport from the Golgi complex to the lysosomes and from the plasma membrane to the lysosomes continued.